X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1362) 1362
Book Review (252) 252
Publication (41) 41
Magazine Article (11) 11
Newsletter (10) 10
Newspaper Article (7) 7
Book Chapter (6) 6
Conference Proceeding (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1041) 1041
humans (831) 831
silver sulfadiazine - therapeutic use (509) 509
male (392) 392
female (338) 338
animals (319) 319
silver (310) 310
wound healing (294) 294
silver sulfadiazine (289) 289
anti-infective agents, local - therapeutic use (270) 270
burns - drug therapy (259) 259
surgery (254) 254
adult (232) 232
nanoparticles (204) 204
middle aged (203) 203
dermatology (197) 197
wound healing - drug effects (193) 193
bandages (186) 186
burns - therapy (182) 182
sulfadiazine (181) 181
administration, topical (159) 159
pharmacology & pharmacy (144) 144
treatment outcome (136) 136
silver sulfadiazine - administration & dosage (135) 135
care and treatment (133) 133
aged (131) 131
silver nanoparticles (130) 130
adolescent (128) 128
burns (127) 127
child (126) 126
rats (126) 126
burns - complications (123) 123
abridged index medicus (122) 122
in-vitro (121) 121
sulfadiazine - therapeutic use (121) 121
health aspects (118) 118
bacteria (114) 114
analysis (108) 108
silver - therapeutic use (108) 108
management (107) 107
wound infection - prevention & control (107) 107
skin (106) 106
anti-bacterial agents - therapeutic use (104) 104
critical care medicine (103) 103
antibacterial activity (96) 96
child, preschool (91) 91
silver - chemistry (91) 91
infection (89) 89
silver - pharmacology (89) 89
anti-bacterial agents - pharmacology (81) 81
antimicrobial activity (81) 81
wounds and injuries (81) 81
mice (80) 80
microbial sensitivity tests (80) 80
wound infection - drug therapy (80) 80
antibiotics (76) 76
cytotoxicity (76) 76
antimicrobial agents (75) 75
infant (75) 75
burns - pathology (74) 74
time factors (74) 74
burns and scalds (73) 73
antibacterial agents (72) 72
toxicity (72) 72
occlusive dressings (71) 71
critical care (70) 70
nursing (70) 70
efficacy (69) 69
nanoscience & nanotechnology (69) 69
prevention (69) 69
burns - microbiology (68) 68
escherichia-coli (68) 68
usage (68) 68
infections (67) 67
prospective studies (67) 67
anti-infective agents, local - administration & dosage (66) 66
microbiology (65) 65
nanotechnology (62) 62
silver sulfadiazine - pharmacology (61) 61
staphylococcus-aureus (59) 59
research (58) 58
skin transplantation (58) 58
disease models, animal (57) 57
silver nitrate - therapeutic use (57) 57
ointments (55) 55
dressings (54) 54
drug combinations (53) 53
wounds (53) 53
pseudomonas aeruginosa - drug effects (52) 52
metal nanoparticles - chemistry (51) 51
pseudomonas aeruginosa (51) 51
retrospective studies (51) 51
bacterial infections - prevention & control (50) 50
burn (50) 50
materials science, biomaterials (50) 50
staphylococcus aureus - drug effects (50) 50
medicine (49) 49
anti-bacterial agents - chemistry (48) 48
anti-infective agents - therapeutic use (48) 48
nanocrystalline silver (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1338) 1338
Chinese (16) 16
French (11) 11
German (8) 8
Russian (6) 6
Italian (3) 3
Portuguese (3) 3
Spanish (2) 2
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Japanese (1) 1
Korean (1) 1
Norwegian (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Critical Care Medicine, ISSN 0090-3493, 11/2010, Volume 38, Issue 11, pp. 2095 - 2102
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0173417 - e0173417
Mast cells (MCs) participate in all stages of skin healing and one of their mediators is the Annexin A1 protein (AnxA1), linked to inflammation, proliferation,... 
CHYMASE | ACTIVATION | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | IN-SITU HYBRIDIZATION | INJURY | LEVEL LASER THERAPY | SKIN | TRYPTASE | FIBROBLASTS | PROTEASES | Rats, Wistar | Silver Sulfadiazine - therapeutic use | Cell Count | Cytoplasm - metabolism | Dermis - drug effects | Histamine - metabolism | Burns - metabolism | Wound Healing - drug effects | Burns - drug therapy | Disease Models, Animal | Epidermis - pathology | Cytokines - metabolism | Epidermis - drug effects | Rats | Macrophages - cytology | Mast Cells - drug effects | Gene Expression Regulation - drug effects | Animals | Mast Cells - cytology | Annexin A1 - metabolism | Dermis - pathology | Macrophages - drug effects | Burns - physiopathology | Cell Proliferation - drug effects | Burns - immunology | Cytoplasm - drug effects | Silver Sulfadiazine - pharmacology | Prevention | Burns and scalds | Care and treatment | Dosage and administration | Mast cells | Research | Annexins | Health aspects | Silver sulfadiazine | Sulfadiazine | Peptides | Laboratories | Biology | A1 protein | Macrophages | Interleukin 6 | Proteins | Cell growth | Phases | Rodents | Fibroblasts | Tumor necrosis factor-TNF | Repair | Burns (injuries) | Wound healing | Cytokines | Albinism | Therapeutic applications | Inflammation | Tumor necrosis factor-α | Burning | Chymase | Studies | Incineration | Interleukin 10 | Stem cells | Tryptase | Healing | Skin | Immunoreactivity | Burns | Monocyte chemoattractant protein 1 | Apoptosis | Index Medicus
Journal Article
Journal Article
Journal of Pediatric Surgery, ISSN 0022-3468, 2012, Volume 47, Issue 6, pp. 1204 - 1207
Journal Article